ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness

PHASE4CompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2012

Conditions
Bipolar Disorder
Interventions
DRUG

aripiprazole

15-30 mg/day aripiprazole, 22 weeks

DRUG

valproate

sufficient dose as determined by investigator to maintain the therapeutic level.

DRUG

placebo

placebo to aripiprazole, 22 weeks

Trial Locations (13)

Unknown

Castle Peak Hospital, Tuenmen

National Center for Mental Health, Mandaluyong

Philippine General Hospital, Manila

University of Sto. Tomas Hospital, Manila

Veterans Medical Memorial Center, Quezon

Changhua Chrisitian Hospital, Changhua

Tsao-Tun Psychiatric Center, Nantou City

Jia-Nan Mental Hospital, Tainan City

National Cheng-Kung University Hospital, Tainan City

Tri-Service General Hospital, Taipei

Taoyuan Mental Hospital, Taoyuan District

Siriraj Hospital, Bangkok

Somdej Chaophraya Hospital, Bangkok

All Listed Sponsors
lead

Korea Otsuka International Asia Arab

INDUSTRY

NCT00484471 - ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness | Biotech Hunter | Biotech Hunter